Clinical Trial Update: Safety and Efficacy Study of GCSF Therapy to Treat Patients at High Risk for Chemotherapy Induced Severe Neutropenia [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating a granulocyte colony-stimulating factor therapy for safety and efficacy in patients at high risk of chemotherapy-induced sever…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer
• Neutropenia

Drugs mentioned

• G-CSF therapy (granulocyte colony-stimulating factor) (granulocyte colony-stimulating factor)

Snippet

Sponsor: AviGenics | Conditions: Breast Cancer, Neutropenia | Phase 2 | Status: COMPLETED